Profile: CLS Bank's Bozian on regulatory co-ops and CCP settlement risk

Regulators are struggling to ensure they have oversight of over-the-counter market infrastructure without losing the benefits of centralisation. CLS Bank’s council of supervisors could be the precedent they follow. By Michael Watt


Reform of the over-the-counter derivatives market is still being finalised, but a new world – built around mandatory clearing, electronic execution and reporting – is beginning to take shape. These measures will help limit systemic counterparty risks, regulators hope, either by mitigating it directly or by shining a light into the previously opaque OTC market so exposures are not allowed to reach dangerous concentrations.

But national interests are making the realisation of this vision difficult

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

Most read articles loading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here